Molecular Genetic and Pathological Studies of Anal Tumors

Trial ID or NCT#

NCT00267787

Status

not recruiting iconNOT RECRUITING

Purpose

Study the Genetics of Anal Cancer

Official Title

Molecular Genetic and Pathological Studies of Anal Tumors

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. Inclusion Criteria: - Patients with anal tumors - Undergoing surgery for elective colon and rectal surgery
Exclusion Criteria:
  1. No other patients other than adult patients with anal cancer or high risk for anal cancer refered to Stanford will be enrolled to the study. No Children will be included to the study
View All Criteria
Show Less

Investigator(s)

Andrew A. Shelton, MD, FACS, FACRS
Andrew A. Shelton, MD, FACS, FACRS
Colorectal surgeon
Clinical Professor, Surgery - General Surgery
Natalie Kirilcuk, MD, FACS
Natalie Kirilcuk, MD, FACS
Colorectal surgeon, Colon and rectal surgeon
Clinical Associate Professor, Surgery - General Surgery

Contact us to find out if this trial is right for you.

Contact

Moe Jalali
650-724-4023

View on ClinicalTrials.gov